Similarly, serum suPAR levels did not differ between patients with a KRAS wild type or KRAS mutated CRC (Supplementary Figure 1D) as well as patients with different ECOG performance status (Supplementary Figure 1E). Here, KRAS is linked to colorectal carcinoma.